Abivax
(ABVX.FP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 365 | 211 |
| Accounts receivable | 4,700 | -677 |
| Accounts payable and accrued liabilities | -22,478 | 5,199 |
| Other Working Capital | -16,966 | 3,921 |
| Other Operating Activity | -16,042 | -43,408 |
| Operating Cash Flow | $-50,421 | $-34,754 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -224 | -12 |
| Purchase Of Investment | N/A | -542 |
| Other Investing Activity | 11,781 | 2,455 |
| Investing Cash Flow | $11,557 | $1,901 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 23,919 | 24,625 |
| Debt Repayment | -3,571 | -2,331 |
| Other Financing Activity | -1,227 | -1,093 |
| Financing Cash Flow | $19,121 | $21,201 |
| Exchange Rate Effect | 451 | 1,319 |
| Beginning Cash Position | 241,608 | 251,942 |
| End Cash Position | 222,317 | 241,608 |
| Net Cash Flow | $-19,742 | $-11,653 |
| Free Cash Flow | ||
| Operating Cash Flow | -50,421 | -34,754 |
| Capital Expenditure | -227 | -12 |
| Free Cash Flow | -50,648 | -34,766 |